Everdime Technologies, Inc.

RGST · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$987-$60-$2,143-$8
Dep. & Amort.-$20$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$23$1$142$95
Other Non-Cash$839-$1$1,967$8
Operating Cash Flow-$71-$58-$33$95
Investing Activities
PP&E Inv.-$3-$7$0$0
Net Acquisitions$39$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$36-$7$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$50$58$34$0
Financing Cash Flow$50$58$34$0
Forex Effect$0$0$0$0
Net Chg. in Cash$15$79$1$0
Supplemental Information
Beg. Cash$0$1$0$4
End Cash$15$80$1$4
Free Cash Flow-$74-$66-$33$95
Everdime Technologies, Inc. (RGST) Financial Statements & Key Stats | AlphaPilot